Aclarion, Inc.
For the period ended Dec 31, 2025. Filed Mar 18, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 18, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Rule 10b5-1 Plans
During the period ended December 31, 2025, no director or officer adopted orterminated (i) any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or (ii) any “non-Rule 10b5-1 trading arrangement” as defined in paragraph (c) of item 408 of Regulation S-K.
2026 Annual Meeting of Stockholders
The Company has established Thursday, June 4, 2026 as the date of the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting") The record date for the determination of stockholders of the Company entitled to receive notice of and to vote at the 2026 Annual Meeting shall be the close of business on Friday, April 10, 2026. The exact time and location of the 2026 Annual Meeting will be specified in the Company's proxy statement for the 2026 Annual Meeting, and it is expected to be a virtual meeting.
Because the date of the 2026 Annual Meeting differs by more than thirty (30) days from the anniversary date of the 2025 Annual Meeting of Stockholders (the "2025 Annual Meeting"), the Company is setting a deadline for receipt of stockholder proposals pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that is a reasonable time before the Company expects to begin to print and send its proxy materials for the 2026 Annual Meeting. In order to be considered for inclusion in the Company's proxy statement and proxy card for the 2026 Annual Meeting, any proposal submitted by a stockholder must be delivered to, or mailed to and received by, the Company's Secretary at the Company's principal executive offices at 8181 Arista Place, Suite 100, Broomfield, Colorado 80021 on or before Saturday, March 28, 2026. Such proposals must comply with the rules of the Securities and Exchange Commission (including the other requirements of Rule 14a-8), and may be omitted if not in compliance with applicable requirements.
In addition, pursuant to the Company’s bylaws, any director nominee or proposal for consideration at the 2026 Annual Meeting submitted by a stockholder other than pursuant to Rule 14a-8 will be considered timely if such proposal or director nomination is received by the Corporate Secretary of the Company at its principal executive offices no later than Saturday, March 28, 2026, which is 10 days after the day on which the date of the 2026 Annual Meeting was first disclosed by the Company. Any such proposal or nomination must meet the requirements set forth in the Company’s bylaws.
Additionally, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must provide notice that sets forth the information required by the Company’s bylaws and Rule 14a-19 under the Exchange Act no later than Monday, April 6, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.